← Leaderboards
Helen H. Hobbs
Ut Southwestern Medical Center
$30,094,310
Attributed
$32,466,523
Total exposure
16
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,466,523 · 16
By mechanism
R01$15,639,276 · 3
P01$11,826,509 · 7
R37$4,472,543 · 1
S10$493,756 · 1
M01$34,439 · 4
Top collaborators
- Jonathan C Cohen8 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Ezra Burstein$12,330,597
- Abhimanyu Garg$28,553,253
- Ronak Lakhia$1,274,410
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularProteinsLiverGrantMutationLipidsVariantCholesterol HomeostasisMetabolismFundingCholesterolHepatocyteHydrolysisIn VivoBaseGeneticMediatingCellsPlasmaIntestinesInsightBiochemicalPlayGenes
Grant awards (70)
Role of ABCG1, ABCG5 and ABCG8 in Sterol Metabolism$689,500
R01 · FY2025 · HL · contact PI
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease$575,584
R01 · FY2025 · DK · contact PI
Post-translational Control of Triglyceride and Cholesterol Metabolism by ANGPTL3 & ANGPTL8 in ApoBCL Clearance$516,600
P01 · FY2025 · HL · contact PI
Role of ABCG1, ABCG5 and ABCG8 in Sterol Metabolism$675,710
R01 · FY2024 · HL · contact PI
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease$552,559
R01 · FY2024 · DK · contact PI
Post-translational Control of Triglyceride and Cholesterol Metabolism by ANGPTL3 & ANGPTL8 in ApoBCL Clearance$516,600
P01 · FY2024 · HL · contact PI
Role of ABCG1, ABCG5 and ABCG8 in Sterol Metabolism$689,500
R01 · FY2023 · HL · contact PI
PNPLA3 in Susceptibility and Resistance to Fatty Liver Disease$575,584
R01 · FY2023 · DK · contact PI
Post-translational Control of Triglyceride and Cholesterol Metabolism by ANGPTL3 & ANGPTL8 in ApoBCL Clearance$574,000
P01 · FY2023 · HL · contact PI
Role of ABCG1, ABCG5 and ABCG8 in Sterol Metabolism$689,500
R01 · FY2022 · HL · contact PI
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2022 · DK · contact PI
Post-translational Control of Triglyceride and Cholesterol Metabolism by ANGPTL3 & ANGPTL8 in ApoBCL Clearance$574,000
P01 · FY2022 · HL · contact PI
Roles of ANGPTL3 and ANGPTL8 in Lipid and Energy Metabolism$649,158
P01 · FY2021 · HL · contact PI
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2021 · DK · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$596,938
R01 · FY2021 · HL · contact PI
Roles of ANGPTL3 and ANGPTL8 in Lipid and Energy Metabolism$649,158
P01 · FY2020 · HL · contact PI
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2020 · DK · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$583,861
R01 · FY2020 · HL · contact PI
Roles of ANGPTL3 and ANGPTL8 in Lipid and Energy Metabolism$649,158
P01 · FY2019 · HL · contact PI
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2019 · DK · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$596,938
R01 · FY2019 · HL · contact PI
Roles of ANGPTL3 and ANGPTL8 in Lipid and Energy Metabolism$649,157
P01 · FY2018 · HL · contact PI
Genetic and Metabolic Basis of Fatty Liver Disease$608,140
R01 · FY2018 · DK · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$581,922
R01 · FY2018 · HL · contact PI
Roles of ANGPTL3 and ANGPTL8 in Lipid and Energy Metabolism$649,157
P01 · FY2017 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$468,454
R37 · FY2017 · HL · contact PI
Role of PNPLA3 in Fatty Liver Disease$345,825
R01 · FY2017 · DK · contact PI
Genetics of Atypical Lipid Disorders$573,631
P01 · FY2016 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$468,454
R37 · FY2016 · HL · contact PI
Role of PNPLA3 in Fatty Liver Disease$345,825
R01 · FY2016 · DK · contact PI
Genetics of Atypical Lipid Disorders$565,028
P01 · FY2015 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$461,426
R37 · FY2015 · HL · contact PI
Role of PNPLA3 in Fatty Liver Disease$345,825
R01 · FY2015 · DK · contact PI
Genetics of Atypical Lipid Disorders$562,159
P01 · FY2014 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$459,084
R37 · FY2014 · HL · contact PI
Role of PNPLA3 in Fatty Liver Disease$345,825
R01 · FY2014 · DK · contact PI
Genetics of Atypical Lipid Disorders$546,098
P01 · FY2013 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$468,454
R37 · FY2013 · HL · contact PI
Role of PNPLA3 in Fatty Liver Disease$352,901
R01 · FY2013 · DK · contact PI
Genetics of Atypical Lipid Disorders$573,332
P01 · FY2012 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$451,585
R37 · FY2012 · HL · contact PI
Role of PNPLA3 in Fatty Liver Disease$365,604
R01 · FY2012 · DK · contact PI
Genetic Approaches to Cholesterol Metabolism in Humans$551,264
P01 · FY2011 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$438,432
R37 · FY2011 · HL · contact PI
Role of PNPLA3 in Fatty Liver Disease$364,550
R01 · FY2011 · DK · contact PI
Genetic Approaches to Cholesterol Metabolism in Humans$553,904
P01 · FY2010 · HL · contact PI
Expression Profiling of Cellular Metabolism Using Massively Parallel Sequencing$493,756
S10 · FY2010 · RR · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$425,622
R37 · FY2010 · HL · contact PI
Genetic Approaches to Cholesterol Metabolism in Humans$539,393
P01 · FY2009 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$421,656
R37 · FY2009 · HL · contact PI
Genetic Approaches to Cholesterol Metabolism in Humans$539,393
P01 · FY2008 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$409,376
R37 · FY2008 · HL · contact PI
Genetic Approaches to Cholesterol Metabolism in Humans$539,393
P01 · FY2007 · HL · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$369,790
R01 · FY2007 · HL · contact PI
METABOLIC AND GENETIC BASIS OF BARE STEROL DISORDERS$2,055
M01 · FY2007 · RR · contact PI
THE GENETICS OF CHOLESTEROL ABSORPTION$1,337
M01 · FY2007 · RR · contact PI
THE PCSK9 GENE: RELATIONSHIP TO HUMAN HEALTH$51
M01 · FY2007 · RR · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$380,835
R01 · FY2006 · HL · contact PI
GENETIC APPROACHES TO CHOLESTROL METABOLISM IN HUMAN SUBJECT$293,782
P01 · FY2006 · HL · contact PI
METABOLIC AND GENETIC BASIS OF RARE STEROL DISORDERS$30,996
M01 · FY2006 · RR · contact PI
Role of ABCG5 and ABCG8 in Sterol Metabolism$390,000
R01 · FY2005 · HL
GENETIC APPROACHES TO CHOLESTROL METABOLISM IN HUMAN SUBJECT$285,226
P01 · FY2005 · HL
Role of ABCG5 and ABCG8 in Sterol Metabolism$390,000
R01 · FY2004 · HL
GENETIC DETERMINANTS OF PLASMA LP(A) CONCENTRATION$351,000
R01 · FY2004 · HL
GENETIC APPROACHES TO CHOLESTROL METABOLISM IN HUMAN SUBJECT$276,918
P01 · FY2004 · HL
Role of ABCG5 and ABCG8 in Sterol Metabolism$390,000
R01 · FY2003 · HL
GENETIC DETERMINANTS OF PLASMA LP(A) CONCENTRATION$351,000
R01 · FY2003 · HL
GENETIC DETERMINANTS OF PLASMA LP(A) CONCENTRATION$351,000
R01 · FY2002 · HL
Genetic approaches to cholesterol metabolism in humans$0
P01 · FY2002 · HL
GENETIC DETERMINANTS OF PLASMA LP(A) CONCENTRATION$351,000
R01 · FY2001 · HL